PTEN and breast carcinoma: Immunoblots confirmed that the PTEN-deficient cells also express abundant levels of full length ERα (ERα66) (Fig. 3A, lane 1) like MCF7 breast carcinoma cells, which were used as a positive control (Fig. 3A, lane 4).